Cipla Health welcomes FSSAI’s new labelling rules for “ORS”, reinforces Prolyte ORS as the #AsliORS ‣ The Orissa Today

Mumbai, 11 Nov 2025 — ProlyteORS, the flagship brand of Cipla Health Limited, welcomes the recent directive from the Food Safety and Standards Authority of India (FSSAI), which mandates the removal of the term “ORS” from food and beverage product names, labels, and trademarks, unless they meet the medically approved formulation of an Oral Rehydration Solution as mandated by the World Health Organisation (WHO).

For Cipla Health, this ruling marks a meaningful alignment between regulatory intent and brand ethos. ProlyteORS is backed by science, approved by WHO, and formulated to deliver the precise balance of electrolytes, glucose, and sodium required for effective therapeutic rehydration. With transparency and integrity at the heart of theirlabelling practices, Cipla Health proudly stands as the #AsliORS, reaffirming their commitment to helping consumers make informed health choices.

Commenting on the development, Mr. Shivam Puri, MD & CEO atCipla Health Limited, said: “The recent FSSAI directive is a significant step towards protecting consumer trust and safeguarding public health by bringing greater transparency and the availability of safe, effective rehydration solutions. At Cipla Health, we have always placed consumer trust at the forefront. Our market leading brand ProlyteORS has always adhered to the highest standards of formulation integrity and #AsliORS is more than a promise—it’s our unwavering commitment to transparency, quality, and efficacy for every consumer.”